Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Study Completion Date

November 30, 2008

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

docetaxel

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

DRUG

vinorelbine tartrate

Trial Locations (24)

160

Tokyo Medical University, Tokyo

466-8560

Nagoya University Hospital, Aichi

078 8510

Asahikawa Medical College, Asahikawa

277-8577

National Cancer Center Hospital East, Chiba-ken

791-0281

National Hospital Organization - Ehime National Hospital, Ehime

820-0018

Aso Iizuka Hospital, Fukuoka

737-0023

National Hospital Organization - Medical Center of Kure, Hiroshima

070-0901

National Hospital Organization - Dohoku National Hospital, Hokkaido

251-8550

Fujisawa City Hospital, Kanagawa

780-8065

National Hospital Organization - Kochi Hospital, Kochi

615-8256

Kyoto-Katsura Hospital, Kyoto

503-8502

Ogaki Municipal Hospital, Ogaki-shi

701-1192

National Hospital Organization - Okayama Medical Center, Okayama

901-2214

National Hospital Organization - Okinawa Hospital, Okinawa

530-0012

Osaka Saiseikai Nakatsu Hospital, Osaka

558-0056

Osaka General Medical Center, Osaka

569-1096

Takatsuki Red Cross Hospital, Osaka

591-8555

National Hospital Organization - Osaka National Hospital, Osaka

362-0803

Saitama Cancer Center, Saitama

760-8571

Takamatsu Red Cross Hospital, Takamatsu

113-8519

Tokyo Medical and Dental University, Tokyo

683-8504

Tottori University Hospital, Tottori

930-0194

Toyama Medical and Pharmaceutical University Hospital, Toyama

933-8555

Koseiren Takaoka Hospital, Toyama

All Listed Sponsors
lead

Japan Multinational Trial Organization

OTHER

NCT00079287 - Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter